C103H137N29O10S4 — CID 157144296
N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]cyclobutanecarboxamide;N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]-2-methoxyacetamide;N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]-3-methoxypropanamide;1-[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]-3-[5-[2-[2-(ethylcarbamoylamino)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]urea (PubChem CID 157144296) has the molecular formula C103H137N29O10S4 and a molecular weight of 2069.69 g/mol. Its IUPAC name is N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]cyclobutanecarboxamide;N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]-2-methoxyacetamide;N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]-3-methoxypropanamide;1-[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]-3-[5-[2-[2-(ethylcarbamoylamino)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]urea.
| Compound Name | N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]cyclobutanecarboxamide;N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]-2-methoxyacetamide;N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]-3-methoxypropanamide;1-[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]-3-[5-[2-[2-(ethylcarbamoylamino)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]urea |
|---|---|
| PubChem CID | 157144296 |
| Molecular Formula | C103H137N29O10S4 |
| Molecular Weight | 2069.69 g/mol |
| Exact Mass | 2068.00 |
| IUPAC Name | N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]cyclobutanecarboxamide;N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]-2-methoxyacetamide;N-[4-[2-[2-[[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]carbamoylamino]-1,3-thiazol-5-yl]ethyl]-2-pyridinyl]-3-methoxypropanamide;1-[3-tert-butyl-1-(cyclopropylmethyl)pyrazol-5-yl]-3-[5-[2-[2-(ethylcarbamoylamino)-4-pyridinyl]ethyl]-1,3-thiazol-2-yl]urea |
| SMILES | CC(C)(C)c1cc(NC(=O)Nc2ncc(CCc3ccnc(NC(=O)C4CCC4)c3)s2)n(CC2CC2)n1.CCNC(=O)Nc1cc(CCc2cnc(NC(=O)Nc3cc(C(C)(C)C)nn3CC3CC3)s2)ccn1.COCC(=O)Nc1cc(CCc2cnc(NC(=O)Nc3cc(C(C)(C)C)nn3CC3CC3)s2)ccn1.COCCC(=O)Nc1cc(CCc2cnc(NC(=O)Nc3cc(C(C)(C)C)nn3CC3CC3)s2)ccn1 |
| InChI | InChI=1S/C27H35N7O2S.C26H35N7O3S.C25H34N8O2S.C25H33N7O3S/c1-27(2,3)21-14-23(34(33-21)16-18-7-8-18)31-25(36)32-26-29-15-20(37-26)10-9-17-11-12-28-22(13-17)30-24(35)19-5-4-6-19;1-26(2,3)20-14-22(33(32-20)16-18-5-6-18)30-24(35)31-25-28-15-19(37-25)8-7-17-9-11-27-21(13-17)29-23(34)10-12-36-4;1-5-26-22(34)29-20-12-16(10-11-27-20)8-9-18-14-28-24(36-18)31-23(35)30-21-13-19(25(2,3)4)32-33(21)15-17-6-7-17;1-25(2,3)19-12-21(32(31-19)14-17-5-6-17)29-23(34)30-24-27-13-18(36-24)8-7-16-9-10-26-20(11-16)28-22(33)15-35-4/h11-15,18-19H,4-10,16H2,1-3H3,(H,28,30,35)(H2,29,31,32,36);9,11,13-15,18H,5-8,10,12,16H2,1-4H3,(H,27,29,34)(H2,28,30,31,35);10-14,17H,5-9,15H2,1-4H3,(H2,26,27,29,34)(H2,28,30,31,35);9-13,17H,5-8,14-15H2,1-4H3,(H,26,28,33)(H2,27,29,30,34) |
| InChIKey | AKNPLEGRXBWDLN-UHFFFAOYSA-N |
| XLogP | 19.93 |
| TPSA | 485.81 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 39 |
| Heavy Atoms | 146 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2069.69 |
| LogP ≤ 5 | 19.93 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 30 |